Inactive Instrument

Highlights Invitrocue Limited

Equities

IVQ

AU000000IVQ8

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Invitrocue Limited Announces Invivocue Pte Ltd Completes Development of its Ace-2 Humanized Immune Mice Platform	20-09-23	CI
Invitrocue Limited Enters into Partnership with Pangaea Oncology SA	20-09-23	CI
Invitrocue Limited, Invitrocue Pte Ltd Sign Binding Memorandum of Understanding with Felipe Eduardo De Almeida E Silva for the Establishment of a Joint Venture Company Called Invitrocue Brazil	20-02-10	CI
Invitrocue Limited Announces Joint Venture with ChinaLink Limited	19-12-06	CI
Invitrocue Limited Reports Earnings Results for the Full Year Ended June 30, 2019	19-10-02	CI
Invitrocue Limited Announces the Establishment of Laboratory Facility in Hong Kong	19-09-27	CI
Invitrocue Limited Announces Clinical Validation Study Underway for Its Onco-Pdotm Test with Klinikum Rechts Der Isar Der Technischen Universität München, Comprehensive Cancer Center Munich, Germany	19-09-24	CI
Invitrocue Commences Clinical Collaboration with National University Hospital Singapore	19-08-07	CI
Invitrocue Limited Announces Unaudited Consolidated Earnings Results for the Half Year Ended December 31, 2018	19-02-27	CI
Invitrocue Limited Creates Joint Venture with Dr. Chen Qingfeng	19-02-10	CI
Invitrocue Limited Signs Agreement with Shanghai Institute of Biochemistry and Cell Biology to Develop Onco-PDO Breast Cancer Models	19-01-22	CI
Invitrocue Roll-Out of Onco-PDO™ Services in Germany	19-01-17	CI
Invitrocue Limited Reports Audited Consolidated and Parent Earnings Results for the Year Ended June 30, 2018	18-09-28	CI
Invitrocue Limited Reports Unaudited Consolidated Earnings Results for the Year Ended June 30, 2018	18-08-31	CI
Invitrocue Launches Personalized Cancer Screening Service Onco-PDO	18-04-12	CI
Invitrocue Limited Reports Unaudited Consolidated Earnings Results for the First Half Year Ended December 31, 2017	18-02-27	CI
Invitrocue Limited Announces Consolidated Financial Results for the Year Ended June 30, 2017	17-08-30	CI
Invitrocue and Genome Institute of Singapore Establish Joint Innovation Laboratory for the Development of in Vitro Cancer Models	17-07-19	CI
Invitrocue Limited Reports Consolidated Earnings Results for the Half Year Ended December 31, 2016	17-02-28	CI
Invitrocue Signs Research Collaboration Agreement with the Garvan Institute of Medical Research	17-02-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Invitrocue Limited

Equities

IVQ

AU000000IVQ8

Highlights

Filters